Double immunofluorescence analysis confirmed that Foxp3+ Tregs expressed CCR4 in the tumor microenvironment (figure 2I), indicating that CCL17–CCR4 axis possibly contributes to the infiltration of Tregs into canine prostate cancer tissues. The gene discussed is CCL17; the disease is prostate cancer.